相关实验视频
Updated: Jul 4, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
主要皮肤CD30-阳性淋巴增殖性疾病-目前的治疗方法,重点是布伦图西马布Vedotin
Tomasz Stein1, Tadeusz Robak2,3, Wojciech Biernat4
1Department of Dermatology, Medical University of Lodz, 90-647 Lodz, Poland.
Journal of clinical medicine
|February 10, 2024
概括
主要皮肤CD30阳性淋巴增殖性疾病,包括淋巴状乳症 (LyP) 和主性皮肤形大细胞淋巴瘤 (pcALCL),越来越多地被了解. 新的CD30向疗法正在成为有前途的治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 主要皮肤CD30阳性淋巴增殖性疾病是皮肤T细胞淋巴瘤的常见子组.
- 这一组包括淋巴状乳病 (LyP),皮肤原发性形大细胞淋巴瘤 (pcALCL) 和相关的边缘性疾病.
研究的目的:
- 审查当前治疗方法的临床证据,用于原发性皮肤CD30阳性淋巴增殖性疾病.
- 讨论新兴的针对CD30的治疗方法.
主要方法:
- 对现有和新型治疗方法的临床证据的文献综述.
- 简要介绍最近在理解这些疾病的遗传学和治疗方面的进展.
主要成果:
- 在了解这些疾病的遗传学和治疗方面取得了重大进展.
- 引入新的针对CD30的药物,包括单克隆抗体,结合抗体 (布伦图西马布维多丁),双特异性抗体和CAR-T细胞疗法.
结论:
- 由于其生物特性,CD30是一种可行的治疗点.
- 新兴的抗CD30疗法对治疗这些淋巴增殖性疾病有前途.
关键词:
有CD30阳性的淋巴瘤.形性大细胞淋巴瘤布伦图西马布 (brentuximab) 在维多丁中被发现.诊断 诊断 诊断 诊断 诊断 诊断淋巴细胞型的帕普洛西斯.主要的皮肤形大细胞淋巴瘤.治疗治疗治疗治疗治疗治疗更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
164
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
164
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
